The authors conducted a literature review about bilateral acute iris transillumination (BAIT) syndrome, a new and relatively unknown syndrome that should be described and made known to the greatest number to avoid potential diagnostic and therapeutic errors. The first cases date back only to 2004 and a total of 79 cases have been published to date, mainly in Europe and especially in Turkey and Belgium. It mainly affects young women between the ages of 30 and 50, and symptoms are often preceded by an upper airway infection. There is also a majority of cases where the onset of the syndrome follows oral intake of moxyfloxacin. The clinical signs are dominated by strong photophobia, secondary to a spectacular transillumination of the iris. Other classical symptoms are conjunctival infection, eye pain, blurred vision, temporary ocular hypertonia, fixed mid-dilated pupils, and pigment dispersion in the anterior chamber with pigmentary deposits in the trabecular meshwork in gonioscopy, symptoms that may be mistaken for uveitis. After a few weeks or months of evolution, persistent sequelae were pupillary atony and chronic and bilateral transillumination of the iris, leading to significant photophobia and sometimes persistent ocular hypertension. The BAIT syndrome is close to the bilateral acute depigmentation of the iris (BADI) syndrome, which is similar to BAIT but lacks associated transillumination. A few cases of patients with BAIT syndrome on one eye and BADI syndrome on the contralateral eye have been described, which confirms some form of link between the two clinical entities.
Patient: Male, 24Final Diagnosis: Bee sting conjunctival injurySymptoms: Eye pain • red eyeMedication: —Clinical Procedure: Ablation of the bee stingSpecialty: OphthalmologyObjective:Unusual clinical courseBackground:Ocular bee stings have been rarely described in the literature, and their management is controversial. A case of conjunctival bee sting with retention of the stinger for 48 hours is presented with a review of the literature on the complications and management of ocular bee sting injury.Case Report:A 22-year-old beekeeper presented to the Emergency Department with mild symptoms from a conjunctival bee sting that he had received 48 hours previously. The stinger was removed in the Emergency Department, and topical antibiotic and anti-inflammatory treatment with corticosteroid were given. There were no complications in this case. However, review of the literature has shown that although the outcome from ocular bee stings can be mild, as in this case, ocular bee stings can result in severe visual symptoms that require amniotic membrane transplant (AMT). Management commonly includes removal of the stinger and both topical and systemic treatment with corticosteroids. The main complications include cataracts, inflammation of the anterior chamber, optic neuropathies, and changes in ocular pressure.Conclusions:Ocular bee stings have been rarely described in the literature, and the management remains controversial. As this case has shown, removal of the stinger and the use of topical treatment with antibiotics and corticosteroids can prevent potentially serious complications that may affect vision. Early and regular follow-up with ocular imaging may be required when symptoms persist.
Previous comparative studies show that triple Descemet membrane endothelial keratoplasty (DMEK) (i.e. phacoemulsification followed immediately by DMEK) has either equivalent or better visual outcomes than DMEK in pseudophakic patients. To resolve this discrepancy, a retrospective cohort study was conducted. All consecutive patients with Fuchs Endothelial Corneal Dystrophy who underwent triple or pseudophakic DMEK in 2015–2019 in a tertiary-care hospital (France) and were followed for >12 months were compared in terms of best spectacle-corrected visual acuity (BSCVA), final refractive outcomes, and endothelial-cell loss at 12 months as well as rebubbling rates. The triple-DMEK (40 eyes, 34 patients) and pseudophakic-DMEK (55 eyes, 43 patients) groups were similar in terms of age and other baseline variables. They also did not differ in final BSCVA (both 0.03 logMAR), final endothelial-cell loss (54% vs. 48%), or astigmatism (-1.25 vs. -1 D). At 12 months, triple-DMEK associated with significantly smaller residual hyperopia (0.75 vs. 1 D; p = 0.04) and spherical equivalence (0 vs. 0.5 D; p = 0.02). Triple-DMEK also tended to associate with more frequent rebubbling (40% vs. 24%, p = 0.09). In conclusion, while triple-DMEK and pseudophakic-DMEK achieved similar visual acuity improvement, triple-DMEK was superior in terms of final sphere and spherical refraction but also tended to have higher complication rates.
Longer battery life is a critically important end user experience for mobile devices such as Ultrabook™. Panel Self Refresh technology allows PSR enabled display to update the images itself thus allowing SoC and link components to be power managed. In addition, power optimized panel designs also help save power while in the PSR mode. This paper overviews mobile PC platform power profile, opportunity and potential for power savings, design considerations of Timing Controller and panel for power optimization and provides a glimpse at the future version of the PSR technology.
Metabolic syndrome is a condition characterized by the clustering of central obesity, hyperglycemia, hypertension, and dyslipidemia. Each abnormality promotes atherosclerosis independently, but when clustered together, these metabolic disorders are increasingly atherogenic and enhance the risk of cardiovascular morbidity and mortality. The prevalence of metabolic syndrome is on the rise, especially in young people, and its onset may he early in life. Therefore, universities are unique settings for early monitoring and intervention of metabolic risk factors. A pilot study was conducted among 100 Lebanese university students (62 male students and 38 female students) aged 18 to 27 years studying at Notre Dame University, Lebanon, to assess the prevalence of obesity and metabolic syndrome and to examine students' eating habits in relation to the consumption of the Mediterranean diet. Parameters measured were weight, height, waist circumference, percentage body fat, blood pressure, and fasting blood glucose level. Metabolic syndrome was evaluated based on the third report of the National Cholesterol Education Program Adult Treatment Panel. Measurements of blood lipid levels, including triglycéride, total cbolesterol, high-density lipoprotein, and low-density lipoprotein, were made for half of the students. Dietary intake was assessed by using a food frequency questionnaire tailored to Lebanese food. Study results indicated that 49% of male students were overweight and 7% were obese compared with 21% overweight and 3% obese female students. Only 4% of students, all men, had the full metabolic syndrome components. However, many students had 1 or more elements of it. Overall, a total of 56% of the students exhibited 1 or more components of metabolic syndrome: 22% of students had 1 component, 30% bad 2 components of the syndrome and 4% had 3 components of metabolic syndrome. In comparison to the traditional Mediterranean Diet Pyramid, those students who had metabolic syndrome had higher consumption of red meat and sweets and a lower consumption of legumes.This considerable prevalence of obesity and metabolic syndrome among students is of concern and may warrant early screening for these disorders. Students' eating habits showed deviation from the traditional Mediterranean Diet Pyramid, so promotional campaigns focusing on the traditional Mediterranean diet may be belpful and necessary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.